➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Merck
Express Scripts
Baxter
Moodys
Harvard Business School

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

Litigation Details for Galderma Laboratories Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Galderma Laboratories Inc. v. Amneal Pharmaceuticals LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Galderma Laboratories Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-11-08 1 Complaint States Patents Nos. 7,749,532 (“the ‘532 patent”); 7,232,572 (“the ‘572 patent”); and 7,211,267 (“the …the ‘267 patent”). (Exhibits A-C.) This action is based upon the Patent Laws of the United States, 35 U.…assignee. A copy of the ‘532 patent is attached as Exhibit A. 13. The ‘532 patent is listed in the U.S. Food…current assignee of the ‘532 patent. 15 . GLI is the licensee of the ‘532 patent. 16. Plaintiffs GLI, GLLP… copy of the ‘572 patent is attached as Exhibit B. "' 18. The ‘572 patent is listed in the Orange External link to document
2012-09-07 104 Memorandum and Order Ashley patents are U.S. Patent Nos. 7,232,572 and 7,211,267. An additional patent, U.S. Patent No. 7,749,532…Abbreviated New Drug Application ("ANDA'') patent litigation, Defendants, Amneal Pharmaceuticals…doxycycline product does not infringe the "Ashley patents." 1 Amneal's Motion is based on collateral…,749,532 (the "Chang patent"), is also asserted against Amneal in this action. (D.I. 1 Exhs.…administered once daily does not infringe the Ashley patents, because such products do not l contain the External link to document
2013-07-30 189 Memorandum Opinion infringement of United States Patent Nos. 7,749,532 ("the '532 patent") and 8,206,740 ("…#39;740 patent") (collectively, the "patents-in-suit" or "Chang patents")…inventor ofthe patents-in-suit. (See D.I. 143 at 10; '532 patent; '740 patent) 2…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which… The '53 2 patent may be found at D .I. 115, J .A. C Ex. 1; the '740 patent may be found at External link to document
2013-09-30 191 Memorandum and Order of the recently-issued U.S. Patent No. 8,206,740 (the "'740 patent"). (D.I. 72, 73, 74) …that litigation counsel improperly participated in patent prosecution. Under the circumstances, the Court… 2011 16 May 2014 1:11-cv-01106 830 Patent None District Court, D. Delaware External link to document
2014-05-16 222 Stipulation of Dismissal three patents—the ’532 patent, U.S. Patent No. 7,232,572 (“the ’572 patent”), and U.S. Patent No. 7,… concerning, among others, U.S. Patent No. 7,749,532 (“the ’532 patent”). On September 14, 2012, Amneal…non-infringement with respect to U.S. Patent No. 8,206,740 (“the ’740 patent”). Case 1:11-cv-01106-LPS Document…alleging infringement only of the ’532 patent and the ’740 patent based on Amneal’s filing of ANDA No. …192,) alleging defenses that the ’532 patent and the ’740 patent are invalid and not infringed, and that External link to document
2014-05-19 223 Patent/Trademark Report to Commissioner Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532; 7,232,572; 7,211,267; 8,206,740… 2011 16 May 2014 1:11-cv-01106 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Moodys
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.